Head-to-head comparison
Embody vs NuuVim
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.
$79/mo (promo rate) sema · $129/mo (promo rate) tirz · Verified July 2026
Marked down on: The $79 flat rate relies on an auto-applied promo 'locked forever' — list price in the terms is $199/mo and reviewers allege the lock isn't honored
Desk Score
NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.
$79/mo (promo rate) sema · $133/mo (promo rate) tirz · Verified August 2026
Marked down on: There is no month-to-month plan: every rate is billed as one three-month payment
Embody takes this head-to-head with the higher Desk Score, 83/100 (B) against 64/100 (C) for NuuVim. NuuVim still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Embody
83/100
B
NuuVim
64/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Embody | NuuVim |
|---|---|---|
| Semaglutide | $79/mopromo rate$79/mo (all doses, promotional rate, compounded) | $79/mopromo rate$79/mo (all doses, 3-mo plan, new patients only, compounded) |
| Tirzepatide | $129/mopromo rate$129/mo (all doses, promotional rate, compounded) | $133/mopromo rate$133/mo (all doses, 3-mo plan, new patients only, compounded) |
| Coverage | All 50 states | Not listed on NuuVim's site (checked August 2026) |
| Brand-name | Compounded only | Yes |
| Oral option | Yes | Yes |
| Best for | Low flat-rate compounded GLP-1 pricing at every dose. | Low-cost compounded GLP-1s (injection or oral), flat all-dose pricing. |
| Desk Score | 83/100B | 64/100C |
The verdict
Desk pick — EmbodyEmbody takes this head-to-head with the higher Desk Score, 83/100 (B) against 64/100 (C) for NuuVim. NuuVim still holds its ground where its strengths line up with yours.
Choose Embody if…
Low flat-rate compounded GLP-1 pricing at every dose.
$79/mo (promo rate) sema · $129/mo (promo rate) tirz · All 50 states
Choose NuuVim if…
Low-cost compounded GLP-1s (injection or oral), flat all-dose pricing.
$79/mo (promo rate) sema · $133/mo (promo rate) tirz
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Embody · NuuVim.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Embody
- CoreAge Rx vs NuuVim
- Embody vs Strut Health
- NuuVim vs Sesame Care
- Embody vs yourEra
- DoctorAdam vs NuuVim
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.